Home>Topics>Stocks>InterMune

InterMune ITMN

  1. All
  2. Commentary
  3. Stock Reports
  4. Headlines
    1. 8 Biotech Events To Anticipate This Year: Part Two

      Headlines

      Mon, 7 Apr 2014

      By Brian Nichols : In this article, I am looking at four more events in biotechnology that could spark substantial gains during the remainder of this year. Already, I have covered four such events including upcoming data announcements, product launches, and FDA approval decisions. In this second ...

    2. Intermune gets a bump from Boehringer's misfortune

      Headlines

      Fri, 21 Mar 2014

      Shares of Intermune ( ITMN +10.2% ) rise after the disclosure of mixed late-stage trial results for Boehringer Ingelheim's rival drug. The company

    3. InterMune shares jump as Boehringer's rival drug shows mixed results

      Headlines

      Fri, 21 Mar 2014

      BANGALORE (Reuters) - Shares of InterMune Inc rose as much as 17 percent on Friday after data showed German drugmaker Boehringer Ingleheim's rival drug had mixed results in late-stage trials.

    4. Positive Phase III Data from Boehringer Ingelheim, but No Clear Winner in IPF Market

      Commentary

      Fri, 21 Mar 2014

      limited detail to directly compare with InterMune ’s Phase III results, the key takeaway ..... Overall, this does not change our view on InterMune ’s prospects as we were anticipating ..... our market model for Esbriet. While InterMune ’s stock is reacting positively to the

    5. Premarket Gainers / Losers

      Headlines

      Fri, 21 Mar 2014

      Gainers: ECYT +145% . UPIP +64% . LIN +32% . MNGA +30% . GNK +24% . MEG +15% . EJ +12% . ITMN +10% . OXGN +7% . IPCI +6% . PRAN +5% . Losers: SYMC -10% . ISR -8% . ICLD -8% . PBF -7% . CMGE -6% . ENLK -5% . Post your comment!

    6. InterMune prices secondary offering

      Headlines

      Fri, 14 Mar 2014

      InterMune ( ITMN ) prices its offering of 7.5M shares of common stock at $32.75/share netting $233M to the company. Overallotment is 1.125M shares. Proceeds will be used to fund Esbriet commercialization . Post your comment!

    7. After Hour Gainers / Losers

      Headlines

      Wed, 12 Mar 2014

      Top gainers, as of 5:15 p.m.: FV +19.4% . CALL +16.9% . KKD +11.0% . IBCP +6.5% . WSM +6.2% . Top losers, as of 5:15 p.m.: MDU -9.1% . MLNK -8.0% . MILL -5.6% . ITMN -3.5% . MUX -3.0% . Post your comment!

    8. InterMune set to price secondary offering

      Headlines

      Wed, 12 Mar 2014

      InterMune ( ITMN ) to offer 7.5M shares of common stock for public sale plus an optional 1.125M shares for underwriters. The company will use

    9. InterMune upgraded

      Headlines

      Tue, 11 Mar 2014

      Goldman Sachs upgrades InterMune ( ITMN ) to Buy with a price target of $45 citing better-than-expected top line Phase 3 results for pirfenidone. 11 of 14 analysts

    10. Midday Gainers / Losers

      Headlines

      Fri, 7 Mar 2014

      SMSI +44% . SKUL +33% . ATAI +25% . PLUG +23% . BIG +21% . ZOOM +20% . OHRP +17% . SPRO +17% . THTI +17% . ITMN +15% . Top 10 Losers: NVTL -25% . PXLW -20% . ALSK -17% . ALOG -17% . TACT -14% . DPW -14% . BAXS -14% . NMRX

    « Prev12345Next »
    Content Partners